Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2023-03-09 Director's Dealing
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
112年02月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider shareholdings and transactions. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2023-03-09 Chinese
112年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on insider shareholdings and related pledges, with no financial statements, earnings data, or management discussion. The content is consistent with a report on insider share transactions or holdings. Given the nature of the data and the focus on insider shareholdings, the document fits best under the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 3187 characters, which is typical for such disclosures and not a brief announcement or a full financial report. Therefore, the classification is DIRS with high confidence.
2023-03-09 Chinese
補充公告有關本公司接獲所投資基金(Spectra SPC Powerfund) 之通知事宜
Regulatory Filings Classification · 95% confidence The document is a supplemental announcement regarding a notification received by the company about its investment fund (Spectra SPC Powerfund). It details the suspension of the fund's net asset value calculation and redemption deferral, the company's redemption request, and its current cash and financing status. The document is short (1501 characters) and serves as a factual update on a specific event affecting the company's financial interests, rather than a full financial report or detailed analysis. It does not contain comprehensive financial statements or management discussion. It is an announcement of a material event related to the company's investment and financial position, fitting the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance disclosure that does not fit other specific categories.
2023-03-06 Chinese
本公司腎病新藥拿百磷 台灣新劑型新適應症三期臨床試驗數據分析達標
Regulatory Filings Classification · 95% confidence The document is a company announcement from a listed company (寶齡富錦生技股份有限公司) reporting clinical trial results for a new drug. It details the trial data, efficacy, safety, and future development plans. The document is short (1697 characters) and focuses on a specific event or update rather than providing comprehensive financial data or a full report. There is no indication that this is a full financial report, audit, or regulatory filing. It is a factual announcement about a clinical trial milestone, which is a material event likely to impact shareholders and the market. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-03-03 Chinese
澄清及說明媒體有關本公司之報導
Regulatory Filings Classification · 95% confidence The document is a short announcement from the company 寶齡富錦生技股份有限公司 clarifying media reports about its investment in a fund and the status of redemption of that investment. It provides factual information about the investment, risk control measures, and potential financial impact, but it does not contain detailed financial statements or comprehensive financial analysis. The document is under 5,000 characters and serves as a regulatory disclosure to clarify facts and update investors on a specific issue. It does not qualify as a full financial report, earnings release, or management discussion. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement clarifying a situation and providing compliance information without constituting a full report or financial statement.
2023-02-16 Chinese
112年1月背書保證與資金貸與
Capital/Financing Update Classification · 90% confidence The document is a financial disclosure from a listed company, 宝龄富锦, providing details about fund lending balances and endorsement guarantees for the current and previous months. It contains tabulated financial data but is very short (610 characters) and does not include comprehensive financial statements or analysis. It appears to be a regulatory disclosure related to capital or financing activities, specifically about fund lending and guarantees. Given the nature of the data and the short length, it is best classified as a Capital/Financing Update (CAP).
2023-02-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.